Evidence map›Paper›PMID 40272669›Full record

ArticleAnnals of surgical oncology2025

Residual Breast Tissue After Four Types of Mastectomy: A Prospective, Comparative Study.

Marcin Jakub Napierała, Wojciech Olszewski, Magdalena Rosińska, Magdalena Okarska-Napierała, Paweł Winter, Aleksander Grous, Zbigniew I Nowecki

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marcin Jakub NapierałaDepartment of Breast Cancer and Reconstructive Surgery, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland. mj.napierala@gmail.com.ORCID http://orcid.org/0000-0002-6820-315X
Wojciech OlszewskiDepartment of Pathology and Laboratory Diagnostics, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Magdalena RosińskaDepartment of Computational Oncology, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Magdalena Okarska-NapierałaDepartment of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland.
Paweł WinterDepartment of Breast Cancer and Reconstructive Surgery, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Aleksander GrousDepartment of Breast Cancer and Reconstructive Surgery, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Zbigniew I NoweckiDepartment of Breast Cancer and Reconstructive Surgery, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResidual breast tissue (RBT), defined as glandular tissue left behind after mastectomy, raises concerns about oncologic safety. However, data on its prevalence and clinical significance remain limited, with existing studies hampered by small sample sizes and inconsistent methodologies. This study evaluated the prevalence of RBT across four mastectomy types-simple mastectomy (SM), modified radical mastectomy (MRM), skin-sparing mastectomy (SSM), and nipple-sparing mastectomy (NSM)-and identified factors influencing its presence.

methodsThis prospective study investigated 350 patients undergoing 403 mastectomies. Tissue samples were collected systematically from eight standardized locations beneath the skin flap for SM, MRM, and SSM, with an additional sample from under the nipple-areolar complex (NAC) for NSM. The study assessed RBT prevalence and associated factors including mastectomy type, breast size, prior surgeries, and surgeon experience.

resultsThe study found RBT in 34.2 % of cases, with no significant differences across mastectomy types (p = 0.71). In NSM, 93 % of the cases had RBT under the NAC. Larger breast size was associated with lower RBT prevalence, whereas prior surgeries significantly increased its occurrence (p = 0.03). Surgeon experience (≥ 50 mastectomies annually) was linked to reduced RBT rates in NSM.

conclusionsResidual breast tissue is a frequent finding regardless of mastectomy type, highlighting the need for standardized evaluation methods and further research into its clinical implications. Tailored surgical approaches and experienced surgeons may help mitigate RBT risk. This study provided critical insights into RBT prevalence and risk factors, offering a foundation for optimizing mastectomy techniques and improving patient outcomes.

Indexed as

BreastBreast NeoplasmsMastectomyNeoplasm, ResidualAdultAgedFemaleFollow-Up StudiesHumansMastectomy, Modified RadicalMiddle AgedNipplesPrognosisProspective StudiesModified radical mastectomy (MRM)Nipple-sparing mastectomy (NSM)Oncological safetyResidual breast tissue (RBT) after mastectomySimple mastectomy (SM)Skin-sparing mastectomy (SSM)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.